Dakrioadenitis

01Pathophysiology

The lacrimal gland sits in the lacrimal fossa of the frontal bone, within the superotemporal orbit. It is divided by the lateral horn of the levator aponeurosis into an orbital lobe (deeper, larger) and a palpebral lobe (superficial, smaller). When this gland becomes inflamed, the swelling produces a characteristic mass effect in the lateral upper lid area.

In acute dacryoadenitis, the mechanism is straightforward infectious inflammation. Viral agents such as EBV, mumps, or adenovirus cause direct glandular infection and reactive lymphoid hyperplasia within the gland. Bacterial dacryoadenitis results from hematogenous seeding or direct extension, most commonly from Staphylococcus aureus or Neisseria gonorrhoeae in sexually active young adults. The gland becomes edematous, infiltrated by neutrophils, and can progress to abscess formation if untreated.

In chronic dacryoadenitis, the pathophysiology reflects the underlying systemic disease. In sarcoidosis, non-caseating granulomas infiltrate the gland. In IgG4-related disease, dense lymphoplasmacytic infiltration with storiform fibrosis replaces normal glandular tissue, leading to a firm, painless enlargement. The reason this distinction matters is that chronic lacrimal gland enlargement on exam should immediately trigger a workup for systemic disease rather than simply prescribing antibiotics.

The S-shaped ptosis is the hallmark physical finding and is directly explained by anatomy. The inflamed gland pushes the lateral portion of the upper lid downward, while the medial lid remains in its normal position. This creates an S-curve when tracing the lid margin from medial to lateral. This is the single most tested physical finding for dacryoadenitis on vignette-based questions.

02Classification and Clinical Manifestation

Dacryoadenitis Classification

Dacryoadenitis vs. Dacryocystitis

This is one of the most commonly confused pairs in ophthalmology questions. Both involve lacrimal structures, but they affect entirely different anatomical locations and present with swelling in different quadrants of the periorbital area.

The key discriminator for vignettes is the location of the swelling. Lateral upper lid points to dacryoadenitis. Medial canthal swelling with epiphora and purulent reflux points to dacryocystitis. Test-writers rely on anatomical localization as the primary way to distinguish these two.

03Diagnostic Workup

The workup is guided by whether the presentation is acute or chronic.

For acute dacryoadenitis, clinical diagnosis is usually sufficient. The combination of rapid-onset lateral upper lid swelling, pain, and S-shaped ptosis in a young patient with viral prodrome is often enough to make the diagnosis without imaging. If the patient has high fever, marked erythema, or the swelling is worsening despite oral antibiotics, CT orbit with contrast is indicated to assess for abscess formation or extension into the orbit.

For chronic dacryoadenitis, the workup must be more aggressive because the differential includes malignancy (lymphoma) and systemic inflammatory disease. A painless, firm lacrimal gland mass that has been present for weeks requires imaging followed by biopsy. The biopsy is the most accurate test and is necessary to distinguish between sarcoidosis (non-caseating granulomas), IgG4-related disease (storiform fibrosis, IgG4-positive plasma cells with an IgG4:IgG ratio greater than 40%), and lymphoma (monoclonal lymphocytic proliferation).

A commonly tested pearl: if a vignette describes bilateral painless lacrimal gland enlargement with submandibular gland swelling and elevated serum IgG4, the answer is IgG4-related disease (formerly called Mikulicz disease). If bilateral lacrimal enlargement appears alongside bilateral hilar lymphadenopathy and erythema nodosum, think sarcoidosis (Heerfordt syndrome if parotid glands and facial nerve palsy are involved).

04Management and Treatment

In acute management, the next best step depends on severity. A well-appearing patient with mild unilateral swelling and no fever can be started on oral antibiotics with close follow-up in 48 to 72 hours. If there is no improvement, imaging is warranted. A toxic-appearing patient with proptosis, restricted extraocular motility, or vision changes needs urgent CT to rule out orbital abscess or cellulitis, followed by IV antibiotics.

For chronic management, the principle is to treat the underlying systemic disease, not the gland in isolation. Corticosteroids are the first-line therapy for both sarcoidosis and IgG4-related dacryoadenitis, but the long-term trajectories differ. Sarcoidosis may require prolonged immunosuppression with steroid-sparing agents such as methotrexate or mycophenolate. IgG4-related disease has a high relapse rate after steroid taper, and rituximab has emerged as the treatment of choice for refractory cases.

A critical contraindication to remember: do not use corticosteroids empirically for a lacrimal gland mass without biopsy first. Steroids can temporarily shrink a lymphoma, masking the diagnosis and delaying appropriate treatment. This is a commonly tested management pitfall.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get dacryoadenitis questions wrong is by confusing the anatomical location with dacryocystitis. When a vignette describes periorbital swelling, students often default to the more familiar diagnosis of dacryocystitis without paying attention to whether the swelling is lateral (lacrimal gland) or medial (lacrimal sac). The test-writer is checking whether you can localize the pathology based on where the swelling sits.

The second trap involves chronic presentations. A painless, bilateral lacrimal gland enlargement is not "just chronic dacryoadenitis" but demands a systemic workup. The vignette may bury clues to sarcoidosis (dry cough, skin nodules, elevated ACE) or IgG4-related disease (autoimmune pancreatitis, submandibular gland swelling) in the stem. Students who focus only on the eye miss the systemic diagnosis entirely.

The third and arguably most dangerous trap is empirically treating a lacrimal gland mass with steroids before obtaining a biopsy. This is a management sequencing question. The correct next step for any chronic lacrimal gland mass is biopsy first, then targeted treatment. Giving steroids without histology risks shrinking a lymphoma and losing the diagnostic window.

Finally, remember the anatomical mnemonic: the lacrimal gland is lateral (both start with "L"), while the lacrimal sac is near the nose (medial). This simple association resolves the majority of localization questions on the exam.